Brand names: Dimethyl Fumarate, Tecfidera
12.1 Mechanism of Action The mechanism by which dimethyl fumarate (DMF) exerts its therapeutic effect in multiple sclerosis is unknown. DMF and the metabolite, monomethyl fumarate (MMF), have been shown to activate the Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway in vitro and in vivo in animals and humans. The Nrf2 pathway is involved in the cellular response to oxidative stress. MMF has been identified as a nicotinic acid receptor agonist in vitro .
8 documented side effects by frequency
No community discussions found for DIMETHYL FUMARATE yet.
Every figure on this page links back to its primary source. See data sources for full provenance.
9 available comparisons
Dosage Forms
Tablet
Route
Oral